Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Anidulafungin
Pfizer Australia Pty Ltd
Medicine Registered
ERAXIS ® _POWDER FOR INJECTION_ _anidulafungin_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ERAXIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking ERAXIS against the benefits it is expected to have for you. If you have any concerns about being given this medicine, ask your doctor or pharmacist. KEEP THIS LEAFLET. You may need to read it again. WHAT ERAXIS IS USED FOR ERAXIS belongs to a group of medicines called echinocandins which work by preventing the growth of fungal organisms causing your infection. ERAXIS is used to treat fungal infections such as invasive candidiasis and candidemia. These are serious fungal infections in your bloodstream or in tissues or organs such as the food pipe or eyes. Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed it for another reason. This medicine is not addictive. This medicine is available only with a doctor's prescription. BEFORE YOU ARE GIVEN ERAXIS _WHEN YOU WILL NOT BE GIVEN_ _ERAXIS_ You will not be given ERAXIS if you have ever had an allergy to: • any medicine containing anidulafungin • any of the ingredients listed at the end of this leaflet • any other similar medicines such as Cancidas (not all brands given). Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; skin rash, itching or hives. _BEFORE YOU ARE GIVEN_ _ERAXIS_ Tell your doctor if you have allergies to any foods, preservatives or dyes or any other medicines. Tell your doctor if you have or have had any of the following medical conditions: • any problems affecting your liver. Your doctor may need to monitor the function of your liver using blood tests. Be sure to follow your doctor's Read the complete document
Version: pfperaxv10412 Supersedes: pfperaxv10311 Page 1 of 15 PRODUCT INFORMATION ERAXIS ® (ANIDULAFUNGIN 100 MG) POWDER FOR INJECTION NAME OF THE MEDICINE Non-proprietary name: anidulafungin Chemical name: 1-[(4R,5R)-4,5-Dihydroxy-N 2 -[[4"-(pentyloxy)[1,1':4',1"- terphenyl]-4-yl]carbonyl]-L-ornithine]echinocandin B. CAS Number: 166663-25-8 ATC code: JO2 AX 06 ERAXIS (anidulafungin) is a semi-synthetic lipopeptide synthesised from a fermentation product of _Aspergillus nidulans_. Anidulafungin is a white to off-white powder that is practically insoluble in water and slightly soluble in ethanol. The empirical formula of anidulafungin is C 58 H 73 N 7 O 17 and the formula weight is 1140.3. THE STRUCTURAL FORMULA IS: DESCRIPTION POWDER FOR INJECTION. ERAXIS is a sterile, lyophilised product for injection that contains anidulafungin. In addition to the active ingredient, anidulafungin, ERAXIS contains the following inactive ingredients: fructose, mannitol, polysorbate 80, tartaric acid and may also contain hydrochloric acid and/or sodium hydroxide. N O NH O HN HO OH H HO H 3 C H H H H NH O OC 5 H 11 CH 3 OH O H H N OH H O H N HO OH H OH H H H O O NH HO H 3 C H H Version: pfperaxv10412 Supersedes: pfperaxv10311 Page 2 of 15 Prior to administration, ERAXIS powder for injection requires reconstitution with water for injections (refer to DOSAGE AND ADMINISTRATION). PHARMACOLOGY MICROBIOLOGY Anidulafungin selectively inhibits 1,3- β-D glucan synthase, an enzyme present in fungal, but not mammalian cells. This results in inhibition of the formation of 1,3- β-D-glucan, an essential component of the fungal cell wall. Anidulafungin has shown fungicidal activity against _Candida_ species and activity against regions of active cell growth of the hyphae of _Aspergillus fum Read the complete document